Ligand validation:3DMT

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3DMT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3DMT_NAD_C_360	87%	38%	0.098	0.97	1.09	1.4	3	6	6	0	100%	1
3DMT_NAD_B_360	64%	41%	0.145	0.946	1.07	1.29	2	7	3	0	100%	1
3DMT_NAD_D_360	58%	40%	0.143	0.923	1.17	1.25	3	4	2	0	100%	1
3DMT_NAD_A_360	30%	42%	0.232	0.897	1.09	1.2	2	3	3	0	100%	1
1ML3_NAD_D_1361	79%	21%	0.121	0.967	1.64	1.81	6	8	2	0	100%	1
3IDS_NAD_D_360	72%	37%	0.112	0.937	1.31	1.24	2	3	1	0	100%	0.9773
1QXS_NAD_D_861	68%	21%	0.142	0.953	1.62	1.83	6	11	0	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.